| Year |
Citation |
Score |
| 2011 |
Patel CG, Kornhauser D, Vachharajani N, Komoroski B, Brenner E, Handschuh del Corral M, Li L, Boulton DW. Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects. Diabetes, Obesity & Metabolism. 13: 604-14. PMID 21332626 DOI: 10.1111/J.1463-1326.2011.01381.X |
0.334 |
|
| 2010 |
Obermeier MT, Yao M, Khanna A, Koplowitz B, Zhu M, Li W, Komoroski B, Kasichayanula S, Discenza L, Washburn W, Meng W, Ellsworth BA, Whaley JM, Humphreys WG. In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans Drug Metabolism and Disposition. 38: 405-414. PMID 19996149 DOI: 10.1124/Dmd.109.029165 |
0.474 |
|
| 2007 |
Mirkov S, Komoroski BJ, Ramírez J, Graber AY, Ratain MJ, Strom SC, Innocenti F. Effects of green tea compounds on irinotecan metabolism. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 35: 228-33. PMID 17108060 DOI: 10.1124/Dmd.106.012047 |
0.493 |
|
| 2006 |
Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sciences. 78: 2105-15. PMID 16427092 DOI: 10.1016/J.Lfs.2005.12.021 |
0.597 |
|
| 2006 |
Ramírez J, Komoroski BJ, Mirkov S, Graber AY, Fackenthal DL, Schuetz EG, Das S, Ratain MJ, Innocenti F, Strom SC. Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenetics and Genomics. 16: 79-86. PMID 16424820 DOI: 10.1097/01.Fpc.0000182784.77630.48 |
0.418 |
|
| 2005 |
Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6972-9. PMID 16203790 DOI: 10.1158/1078-0432.Ccr-04-2488 |
0.631 |
|
| 2005 |
RAMIREZ J, INNOCENTI F, KOMOROSKI B, MIRKOV S, YODERGRABER A, FACKENTHAL D, DAS S, SCHUETZ E, STROM S, RATAIN M. Genetic determinants of UGT1A1 inducibility Clinical Pharmacology & Therapeutics. 77: P25-P25. DOI: 10.1016/J.Clpt.2004.11.096 |
0.313 |
|
| 2004 |
Komoroski BJ, Zhang S, Cai H, Hutzler JM, Frye R, Tracy TS, Strom SC, Lehmann T, Ang CY, Cui YY, Venkataramanan R. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 512-8. PMID 15100173 DOI: 10.1124/Dmd.32.5.512 |
0.672 |
|
| 2001 |
Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, Venkataramanan R, Cai H, Sinal CJ, Gonzalez FJ, Schuetz JD. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. The Journal of Biological Chemistry. 276: 39411-8. PMID 11509573 DOI: 10.1074/Jbc.M106340200 |
0.615 |
|
| 2000 |
Venkataramanan R, Ramachandran V, Komoroski BJ, Zhang S, Schiff PL, Strom SC. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 28: 1270-3. PMID 11038151 |
0.639 |
|
| 1999 |
Ramachandran V, Kostrubsky VE, Komoroski BJ, Zhang S, Dorko K, Esplen JE, Strom SC, Venkataramanan R. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 27: 1194-9. PMID 10497147 |
0.634 |
|
| 1999 |
Venkataramanan R, Ramachandran V, Kostrubsky VE, Komoroski B, Zuckerman S, Dorko K, Esplen J, Strom SC. USE OF PRIMARY CULTURES OF HUMAN HEPATOCYTES FOR EVALUATING PHASE 2 METABOLISM USING MYCOPHENOLIC ACID. Therapeutic Drug Monitoring. 21: 440. DOI: 10.1097/00007691-199908000-00055 |
0.573 |
|
| Show low-probability matches. |